Elevated Basal Autophagy in SF3B1 Mutated Myelodysplastic Syndromes: Relationship with Survival Outcomes and Therapeutic Implications
Valeria Visconte(Cleveland Clinic), Jennifer S. Carew(University of Arizona), Mikkael A. Sekeres(University of Miami), Steffan T. Nawrocki(University of Arizona), Heesun J. Rogers(Cleveland Clinic), Anjali S. Advani(Cleveland Clinic), Jaroslaw P. Maciejewski(Cleveland Clinic), Kevin R. Kelly(Keck Hospital of USC), Yingchun Han(Cleveland Clinic), Hetty E. Carraway(Cleveland Clinic)
Cited by 1
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782